Skip to main content

COVID 19 Updates from RheumNow

Great and Not So Great (9.30.2022)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

COVID-19 Arthropathy and Myalgia

An online survey of random COVID-19 infected persons shows that arthralgia and myalgia are common consequences to COVID-19 infection.

2022 Lasker Award Winners

EurekAlert!

The Lasker Foundation has announced the winners of its 2022 Lasker Awards: Richard O. Hynes (Massachusetts Institute of Technology), Erkki Ruoslahti (Sanford Burnham Prebys) and Timothy A.

Heavy Metal Rheumatology (9.23.2022)

Thanks to all of you for your kind comments and great reviews of our weekly podcast.

COVID Outcomes in Dermatomyositis

A retrospective study of dermatomyositis (DM) patients with COVID-19, shows that DM patients without comorbidities fair well (with regard to mortality and hospitalisation).

Does Fibromyalgia Need B12? (9.9.2022)

Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if Sjogren's will develop lymphoma? Let's dive in and review these journal reports and this past week's news from RheumNow.com.

Goofy But True

Dr. Jack Cush discusses declining survival rates in the USA, FDA approvals of new COVID subvariant boosters and other odd and possibly true new research reports from the past week on RheumNow.com.

FDA Approves BA.4 and BA.5 Omicron COVID Booster Vaccines

Today the FDA authorized the updated Omicron subvariant (BA.4 and BA.5) COVID-19 booster shots manufactured by Pfizer and Moderna; with an anticipated ship/start date of early September 2022. The BA.5 subvariant accounts for more than 88% of U.S. infections.

Influenza Vaccination Recommendations

CDC

The CDC has published an update to the recommendations from the Advisory Committee on Immunization Practices (ACIP) on the use of seasonal influenza vaccines in the United States for the 2022-23 season.

Hit Parade Review (8.12.2022)

We've got a lot to discuss this week: psoriasis; fatigue; sleep; sural nerve biopsies; uveitis and SpA; diet and RA; tofacitinib and the ORAL surveillance study; what not to take with mycophenolate - and more. In what order should these items be discussed?

The Great Unknowns (8.5.2022)

Dr. Jack Cush reviews the news, FDA approvals, journal articles from the past week on RheumNow; plus viewer questions. This week great hopes for vitamin D, the great unknows of CSA and the great big mess that is the gout.

ACR Updated Guideline on Vaccinations for Rheumatic Patients

The ACR has posted a new ACR Clinical Practice Guideline Summary providing recommendations on the use of vaccinations for children and adults with rheumatic and musculoskeletal diseases (RMDs).

Social

"Double blind" an interesting read (Ann Int Med) of early COVID w/ no known effective therapy, doctor trepidation & and the bravery/will of sick ICU COVID pts as they consent to to enroll in the blinded ACTT trial w/ remdesivir https://t.co/N2bZq0JDmn https://t.co/iPLnNtQoER
Dr. John Cush @RheumNow ( View Tweet )
1 day 8 hours ago
Metanalysis of 25 studies examined effects of NSAID therapy on COVID-19 outcomes and confirms NSAIDs do not increase the likelihood of SARS-CoV-2 infection and do not worsen outcomes in patients with COVID-19. https://t.co/FAJ58stmv1

Dr. John Cush @RheumNow ( View Tweet )

1 week 1 day ago
Are we set for the next "Twindemic"? - Continuation and evolution of COVID BA.5 to? - Flourishing Influenza in a population who has vaccine burnout? Some predicting severe flu based on Australia’s 2022 flu season, climate change, more https://t.co/qWuhWjaAFa

Dr. John Cush @RheumNow ( View Tweet )

1 week 1 day ago
New CDC data on vaccination/boosters during BA.5 wave for deaths, age 50+https://t.co/HGyjNwUveDCompared w/unvaccinated: —92% reduction of death for 4 shots —No difference in reduction between 3 and 2 shots (~82%) [that's a 12-fold ⬇️risk of death for 4 shots in July 2022] https://t.co/3JDjCLbEyh
Eric Topol @EricTopol ( View Tweet )
1 week 3 days ago
New download available! COVID Deaths at 3 Mos vs. 30 Mos https://t.co/SLGJGh5NX1 https://t.co/QhWdvNHntk
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 2 days ago
Provacative read from @VPrasadMDMPH on why we no longer need to or should wear masks in our clinics and hospitals (Yes, with COVID+ pts --- No, everywhere else). My advice: wear masks in high risk environments/situations. https://t.co/cECeieQ2YL https://t.co/PbX8xnfgqM
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 2 days ago
The Atlantic has published an insightful article on "Brain Fog", especially as a Long Covid consequence (IMHO: Brain fogs primary cause is poor sleep, fibromyalgia, chronic fatigue - but can be complication to primary CNS events) https://t.co/SlwzRDSVSf https://t.co/qrBvV5oyUA
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 3 days ago
In your RHEUMATOLOGY practice how often are you seeing #LongCovid (new fatigue,brainfog,breathless etc) in your immune dis pts with COVID ( i.e. > 1 month) @CCalabreseDO @jeffsparks @zach_wallace_md @philipcrobinson @JYazdanyMD @alhkim @RheumNow @EBRheum @rheum_cat @AWIRGROUP

Leonard Calabrese @LCalabreseDO ( View Tweet )

2 weeks 4 days ago
COVID Outcomes in Dermatomyositis A retrospective study of dermatomyositis (DM) patients with COVID-19, shows that DM patients without comorbidities fair well (with regard to mortality and hospitalisation).https://t.co/nlCVHt3XeS https://t.co/Bhc47k7rMD
Dr. John Cush @RheumNow ( View Tweet )
2 weeks 4 days ago
Head Scratcher? Study of UK Biobank cohort (n=380,380) shows those taking Rx Folate had increased risk of COVID-19 Dx (OR 1.51; 1.42–1.61) and Death (OR 2.64; 2.15–3.24). MTX use (+/- folate) had no increase in COVID or COVID death(1.07;0.57–1.98) https://t.co/MLE1sL7KG2 https://t.co/adoLO9qLON
Dr. John Cush @RheumNow ( View Tweet )
4 weeks ago
×